Dendritic release of dopamine in the substantia nigra.

Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (1987) 2.65

Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2003) 1.87

Activity-dependent regulation of synapses by retrograde messengers. Neuron (2009) 1.73

Dopamine release in the basal ganglia. Neuroscience (2011) 1.67

Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol (2004) 1.35

Control of extracellular dopamine at dendrite and axon terminals. J Neurosci (2010) 1.33

Electrophysiological evidence for facilitatory control of oxytocin neurones by oxytocin during suckling in the rat. J Physiol (1984) 1.32

Mechanisms governing dendritic gamma-aminobutyric acid (GABA) release in the rat olfactory bulb. Proc Natl Acad Sci U S A (2001) 1.31

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev (2011) 1.29

Mechanisms and function of dendritic exocytosis. Neuron (2011) 1.28

An ultra-short dopamine pathway regulates basal ganglia output. J Neurosci (2009) 1.23

Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J Neurosci (2009) 1.19

Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area. Neuropsychopharmacology (2008) 1.15

The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci U S A (1995) 1.11

The time course of dopamine transmission in the ventral tegmental area. J Neurosci (2009) 1.10

The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience (2014) 1.10

An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles. J Cell Biol (2001) 1.07

Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol (2006) 1.07

Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron (2013) 1.06

Extrasynaptic exocytosis and its mechanisms: a source of molecules mediating volume transmission in the nervous system. Front Physiol (2012) 1.04

Neurotransmitters and peptides: whispered secrets and public announcements. J Physiol (2008) 1.04

Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways. PLoS One (2012) 1.01

Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS One (2009) 1.00

Calcium dependence of depolarization-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J Physiol (1999) 0.99

Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PLoS One (2011) 0.99

Role of nitric oxide on motor behavior. Cell Mol Neurobiol (2005) 0.97

Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl) (2010) 0.93

Responses of rat substantia nigra compacta neurones to L-DOPA. Br J Pharmacol (1990) 0.92

Intrinsic and integrative properties of substantia nigra pars reticulata neurons. Neuroscience (2011) 0.92

Ultrastructural localization and function of dopamine D1-like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. Eur J Neurosci (2010) 0.91

Colocalization of FM1-43, Bassoon, and GnRH-1: GnRH-1 release from cell bodies and their neuroprocesses. Endocrinology (2011) 0.91

The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. Br J Pharmacol (1989) 0.89

Chemical transmission between dopaminergic neuron pairs. Proc Natl Acad Sci U S A (2008) 0.88

Two different inward rectifier K+ channels are effectors for transmitter-induced slow excitation in brain neurons. Proc Natl Acad Sci U S A (2002) 0.88

The timing of dopamine- and noradrenaline-mediated transmission reflects underlying differences in the extent of spillover and pooling. J Neurosci (2014) 0.86

Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Psychopharmacology (Berl) (2005) 0.86

Ca(2+) and frequency dependence of exocytosis in isolated somata of magnocellular supraoptic neurones of the rat hypothalamus. J Physiol (2003) 0.84

Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone. Proc Natl Acad Sci U S A (1995) 0.84

In vivo measurement of somatodendritic release of dopamine in the ventral tegmental area. Synapse (2009) 0.83

Somatodendritic dopamine release: recent mechanistic insights. Philos Trans R Soc Lond B Biol Sci (2015) 0.83

Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. J Neurosci (2012) 0.81

Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. J Neurophysiol (2011) 0.81

Comparative Ultrastructural Analysis of D1 and D5 Dopamine Receptor Distribution in the Substantia Nigra and Globus Pallidus of Monkeys. Adv Behav Biol (2009) 0.81

Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine. Front Syst Neurosci (2011) 0.80

Autoinhibition of serotonin cells: an intrinsic regulatory mechanism sensitive to the pattern of usage of the cells. Proc Natl Acad Sci U S A (1999) 0.79

Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area. Front Syst Neurosci (2011) 0.79

The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines. Basal Ganglia (2011) 0.78

The h-current in the substantia Nigra pars compacta neurons: a re-examination. PLoS One (2012) 0.78

Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output. J Neurophysiol (2014) 0.77

Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action. J Physiol (2002) 0.77

The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats. Psychopharmacology (Berl) (2004) 0.77

From Ethanol to Salsolinol: Role of Ethanol Metabolites in the Effects of Ethanol. J Exp Neurosci (2016) 0.77

Psychosis from subthalamic nucleus deep brain stimulator lesion effect. Surg Neurol Int (2013) 0.76

Postactivation inhibition of spontaneously active neurosecretory neurons in the medicinal leech. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2006) 0.76

Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain. Synapse (2016) 0.75

Dendritic Release of Neurotransmitters. Compr Physiol (2016) 0.75

Morphology, projection pattern, and neurochemical identity of Cajal's "centrifugal neurons": the cells of origin of the tectoventrogeniculate pathway in pigeon (Columba livia) and chicken (Gallus gallus). J Comp Neurol (2014) 0.75

Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. J Neural Transm (Vienna) (2010) 0.75

Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. Int J Neuropsychopharmacol (2014) 0.75

Dopamine D1 Receptor Immunoreactivity on Fine Processes of GFAP-Positive Astrocytes in the Substantia Nigra Pars Reticulata of Adult Mouse. Front Neuroanat (2017) 0.75

Subcellular Patch-clamp Recordings from the Somatodendritic Domain of Nigral Dopamine Neurons. J Vis Exp (2016) 0.75

DA Negatively Regulates IGF-I Actions Implicated in Cognitive Function via Interaction of PSD95 and nNOS in Minimal Hepatic Encephalopathy. Front Cell Neurosci (2017) 0.75

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (1998) 2.53

Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus (2000) 2.18

Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. Medicine (Baltimore) (1999) 2.11

The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03

Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature (1995) 1.83

Dopaminergic terminals in the rat cortex. Science (1973) 1.73

Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci (1997) 1.66

G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci (1993) 1.66

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66

Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J Neurosci (1997) 1.62

Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J Neurochem (1988) 1.61

Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58

Selective activation of mesocortical DA system by stress. Nature (1976) 1.56

High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol (1998) 1.54

Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52

Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci (1996) 1.51

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport (1994) 1.46

Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res (1989) 1.45

Stimulation of dopamine release by GABA in rat striatal slices. Brain Res (1978) 1.45

Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci (1998) 1.44

Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43

Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron (1991) 1.40

Inhibition by hemicholinium-3 of (14C)acetylcholine synthesis and (3H)choline high-affinity uptake in rat striatal synaptosomes. Mol Pharmacol (1973) 1.36

Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J Neurosci (1998) 1.36

Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. J Pharmacol Exp Ther (1968) 1.33

Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res (1989) 1.32

The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30

Anatomical and electrophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res (1987) 1.29

Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26

Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23

A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23

Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res (1984) 1.23

Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides (1992) 1.21

Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature (1984) 1.20

Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience (1988) 1.19

Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci (1997) 1.19

Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol (1973) 1.19

Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18

Catecholaminergic depressant effects on bulbar respiratory mechanisms. Brain Res (1979) 1.16

Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res (1980) 1.16

Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13

Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res (1976) 1.13

Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13

Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem (1998) 1.13

Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol (1978) 1.11

Segregation and convergence of information flow through the cortico-subthalamic pathways. J Neurosci (2001) 1.11

Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature (1980) 1.09

Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol (2000) 1.09

Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience (1992) 1.09

Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci (1994) 1.08

Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat. J Pharmacol Exp Ther (1977) 1.08

Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons. Eur J Pharmacol (1971) 1.07

Acetylcholine synthesis from (2- 14 C)pyruvate in rat striatal slices. J Neurochem (1973) 1.06

Inhibition of dopamine release in the cat caudate nucleus by nigral application of glycine. Eur J Pharmacol (1978) 1.05

In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci U S A (1979) 1.05

A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol Pharmacol (1984) 1.04

Effects of drugs on the disposition of H-3-norepinephrine in the rat brain. Pharmacol Rev (1966) 1.04

Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem (1991) 1.04

Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J Neurochem (1999) 1.02

Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci U S A (1969) 1.02

[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. Presse Med (1997) 1.02

The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.02

Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. Eur J Neurosci (2001) 1.01

Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J Neurosci (1999) 1.01

Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem (1995) 1.01

Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem Pharmacol (1966) 1.01

Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00

An abundant mRNA of the embryonic brain persists at a high level in cerebellum, hippocampus and olfactory bulb during adulthood. Eur J Neurosci (1993) 1.00

Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett (1992) 1.00

Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00

Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum. J Neurochem (1971) 1.00

Gap junctional communication and pharmacological heterogeneity in astrocytes cultured from the rat striatum. J Physiol (1998) 0.99

Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat. Brain Res (1978) 0.97

[3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J Neurochem (1987) 0.97

Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat. Brain Res (1978) 0.97

Dopamine uptake in serotoninergic terminals in vitro: a valuable tool for the histochemical differentiation of catecholaminergic and serotoninergic terminals in rat cerebral structures. Brain Res (1978) 0.96

Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res (1975) 0.96

The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem (1996) 0.96

Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. Proc Natl Acad Sci U S A (1991) 0.96

Endothelins regulate astrocyte gap junctions in rat hippocampal slices. Eur J Neurosci (2004) 0.96

Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists. Br J Pharmacol (1993) 0.95

Release of dopamine in vivo from cat substantia nigra. Nature (1977) 0.95

Ontogenesis of neostriatal cholinergic neurones in the rat and development of their sensitivity to neuroleptic drugs. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.95

Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience (1993) 0.95

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. Eur J Pharmacol (1970) 0.95

A neuroglial cooperativity is required for the potentiation by 2-chloroadenosine of the muscarinic-sensitive phospholipase C in the striatum. J Neurosci (1989) 0.94

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res (1998) 0.94

Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus. Proc Natl Acad Sci U S A (1989) 0.94

Storage and synthesis of norepinephrine in the reserpine-treated rat brain. J Pharmacol Exp Ther (1966) 0.94

L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience (1992) 0.93

Plasma tryptophan and 5-HT metabolism in the CNS of the newborn rat. J Neurochem (1974) 0.93

Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience (1996) 0.93